ABVC BioPharma, Inc. (ABVC)
1.00
+0.02
(+2.04%)
USD |
NASDAQ |
Oct 09, 16:00
1.00
0.00 (0.00%)
Pre-Market: 20:00
ABVC BioPharma Market Cap : 25.77M for Oct. 9, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 09, 2026 | 25.77M |
| October 08, 2026 | 25.25M |
| October 07, 2026 | 25.77M |
| October 06, 2026 | 24.99M |
| October 05, 2026 | 25.25M |
| October 02, 2026 | 26.03M |
| October 01, 2026 | 26.28M |
| September 30, 2026 | 27.31M |
| September 29, 2026 | 26.80M |
| September 28, 2026 | 27.06M |
| September 25, 2026 | 29.12M |
| September 24, 2026 | 28.09M |
| September 23, 2026 | 29.38M |
| September 22, 2026 | 29.89M |
| September 21, 2026 | 29.63M |
| September 18, 2026 | 29.89M |
| September 17, 2026 | 29.63M |
| September 16, 2026 | 27.83M |
| September 15, 2026 | 27.57M |
| September 14, 2026 | 25.77M |
| September 11, 2026 | 25.25M |
| September 10, 2026 | 25.15M |
| September 09, 2026 | 24.99M |
| September 08, 2026 | 27.31M |
| September 04, 2026 | 24.74M |
| Date | Value |
|---|---|
| September 03, 2026 | 25.77M |
| September 02, 2026 | 22.28M |
| September 01, 2026 | 21.27M |
| August 31, 2026 | 22.10M |
| August 28, 2026 | 21.39M |
| August 27, 2026 | 20.50M |
| August 26, 2026 | 18.32M |
| August 25, 2026 | 20.61M |
| August 24, 2026 | 21.64M |
| August 21, 2026 | 23.14M |
| August 20, 2026 | 23.14M |
| August 19, 2026 | 24.35M |
| August 18, 2026 | 22.53M |
| August 17, 2026 | 22.10M |
| August 14, 2026 | 23.40M |
| August 13, 2026 | 24.95M |
| August 12, 2026 | 24.97M |
| August 11, 2026 | 25.62M |
| August 10, 2026 | 24.71M |
| August 07, 2026 | 26.53M |
| August 06, 2026 | 26.53M |
| August 05, 2026 | 26.27M |
| August 04, 2026 | 27.83M |
| August 03, 2026 | 27.05M |
| July 31, 2026 | 26.27M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Anika Therapeutics, Inc. | 262.04M |
| Perspective Therapeutics, Inc. | 303.47M |
| MiMedx Group, Inc. | 680.53M |
| Abbott Laboratories | 172.35B |
| AngioDynamics, Inc. | 488.73M |
Market Cap Related Metrics
| PEG Ratio | -0.081 |
| Price to Book Value | 2.505 |
| Price | 1.00 |
| Earnings Yield | -28.78% |
| PEGY Ratio | -0.081 |